N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-L-cyclohexylglycine>98.0%(HPLC)(T)5g

4-((4-chloro-3-(trifluoromethyl)phenyl)sulfonamido)benzoic acid, 95.0%, 500mg

anti-Glial Fibrillary Acidic Protein mouse monoclonal, GF 12.24, 1 ml

7-Chloro-1-methyl-1H-pyrazolo[3,4-c]pyridine, 95.0%, 5g

tert-butyl 2-iodo-3H,4H,5H,6H,7H-imidazo[4,5-c]pyridine-5-carboxylate, 97%, 5g

4-Bromo-1-methyl-2-(o-tolyl)-1H-imidazole, 97%, 100mg

5-(2,5-Dimethylphenoxy)pentanoic acid, 97%, 5g

(R)-2-Amino-2-(3-(methylthio)phenyl)ethanol hydrochloride, 95.0%, 250mg

(4-((Furan-2-ylmethoxy)methyl)phenyl)boronic acid, 95.0%, 250mg

Sodium AAS standard solution, ROTI®Star, 100 ml, HDPE

3,3-Dimethyl-3H-indole-4-carboxylic acid, 90.0%, 100mg

Cylinder Round Ø 70 mm in highest adjustable top layer of black glass and micrometer graduation of 0.01 mm.

1-Benzyl-4-hydroxypiperidine, 97.0%, 500g